Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

NYAB - Builder of the green revolution (republished)

15 september 2024

<p><a id="bm-comp-3ec24774-1460-45b2-b558-7b624fe1ac83" class="BMCustomAnchor" name="bm-comp-3ec24774-1460-45b2-b558-7b624fe1ac83"></a></p> <table> <tbody> <tr> <td style="vertical-align: top; width: 100.000000%;"> <ul> <li>A niched construction company focused on the green transition</li> <li>Smart project selection, and a variable cost structure</li> <li>Fair value range of SEK 5.5-7.5, implying a 11-16x '25e EV/EBIT</li> </ul> </td> </tr> </tbody> </table> <p><a id="bm-comp-afe6b97d-06bc-4975-b807-89a41924d2fd" class="BMCustomAnchor" name="bm-comp-afe6b97d-06bc-4975-b807-89a41924d2fd"></a></p> <table> <tbody> <tr> <td style="vertical-align: top; width: 100.000000%;"> <h3 class="bm-h3">Building the infrastructure for the green transition</h3> <p><span style="color: #ff0000;">Republished to correct erroneous '25e EV/EBIT.</span></p> <p>NYAB is a specialised contractor of infrastructure and energy projects in Sweden and Finland. It assumed its current form in the spring of 2022 through a reverse takeover of the listed Finnish company Skarta Group. In June 2024, the company moved its headquarters to Lule&aring; and relisted its shares on the First North Premier Growth Market Stockholm after previously being listed in Finland. The group is headed by its founder and major shareholder, CEO Johan Larsson.</p> <h3 class="bm-h3">Targeting complex projects with asset-light operating model</h3> <p>NYAB stands to benefit from market tailwinds like urbanisation, infrastructure investments, and the green energy transition. In projects, NYAB acts as the main contractor overseeing project management and coordinating subcontractors. This allows it to maintain an asset-light operating model and a variable cost structure. The construction business is all about mitigating risk, which NYAB handles by selecting projects with sufficient complexity, up-selling potential beyond the initial tender scope, and potential for follow-on business with the customer. NYAB has ~450 employees, of which ~70% are white-collar.</p> <h3 class="bm-h3">Strong EPS growth and limited re-investment need</h3> <p>We estimate '24-'26 revenue growth of 13-10%, in line with company targets. We forecast EPS to grow by 52-22% in '24-'26 and for net debt to remain negative for the remainder of the period. We prefer a combined earnings multiple and discounted cash flow valuation. In light of higher margins and low leverage, we believe NYAB deserves a valuation above legacy construction peers. But due to lower returns on equity, we believe it should not trade at the top of the peer range. We arrive at a fair value of SEK 5.5-7.5, implying a '25e EV/EBIT multiple of 11-16x.</p> </td> </tr> </tbody> </table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2025-11-07 Clavister - Improving margins backed by cost control Clavister Analys
2025-11-07 Infrea - A quarter in the right direction Infrea Analys
2025-11-07 Cavotec - Short-term softness from project timing Cavotec Analys
2025-11-07 Inission - Inission much better y-o-y, Enedo hold... Inission Analys
2025-11-06 Viscaria - Filling the coffers Viscaria Analys
2025-11-06 NYAB - Solid margin resilience amid strong growth NYAB Analys
2025-11-06 G5 Entertainment - Finally, better growth momentum G5 Entertai.. Analys
2025-11-06 Arctic Paper - Strong paper Arctic Paper Analys
2025-11-06 Clavister - In line with pre-announcement Clavister Analys
2025-11-05 Ascelia Pharma - Continuing to position itself fo... Ascelia Pharma Analys
2025-11-05 Bredband2 - ARPU gains outweigh churn pains Bredband2 Analys
2025-11-05 OrganoClick - Cost savings to cushion volume head... OrganoClick Analys
2025-11-05 Medicover - Execution remains solid Medicover Analys
2025-11-05 SinterCast - Market headwinds in '25, set for gro... SinterCast Analys
2025-11-05 OrganoClick - Challenging Q3, but cost-cutting un... OrganoClick Analys
2025-11-05 G5 Entertainment - Guides for accelerated growth ... G5 Entertai.. Analys
2025-11-05 Embellence Group - Putting a number on DTC growth Embellence .. Analys
2025-11-05 NYAB - 32% organic growth, but slight margin miss NYAB Analys
2025-11-05 SinterCast - Sales pre-announced but somewhat bet... SinterCast Analys
2025-11-05 Medicover - Margins expand, despite slower growth Medicover Analys